B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions.
about
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectivesCurrent and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)Anti-Neutrophil Cytoplasmic Antibody Pathogenesis in Small-Vessel VasculitisPathogenesis of ANCA-associated vasculitisThe immunopathology of ANCA-associated vasculitisSingle cell analysis of B lymphocytes from Wegener's granulomatosis: B cell receptors display affinity maturation within the granulomatous lesions.Pathogenesis of ANCA-associated vasculitis.Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitis.Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?Biological therapies: new treatment options for ANCA-associated vasculitis?ANCA-associated vasculitis: new options beyond steroids and cytotoxic drugs.Current state of biologicals in the management of systemic vasculitis.The infectious etiology of vasculitis.T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?Pathogenesis of ANCA-associated vasculitis, an update.Current understanding of the pathogenesis of granulomatosis with polyangiitis (Wegener's).Granuloma in ANCA-associated vasculitides: another reason to distinguish between syndromes?Impact of rituximab trials on the treatment of ANCA-associated vasculitis.Treatment of granulomatosis with polyangiitis (Wegener's).Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis.Single-dose rituximab for remission induction and maintenance therapy in ANCA-associated vasculitis: a retrospective analysis of 17 patients.Kv1.3 Channel Blockade Modulates the Effector Function of B Cells in Granulomatosis with Polyangiitis.Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis?Mathematical analysis of antigen selection in somatically mutated immunoglobulin genes associated with autoimmunity.Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis.Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial.Decreases in the numbers of peripheral blood regulatory T cells, and increases in the levels of memory and activated B cells, in patients with active eosinophilic granulomatosis and polyangiitis.Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener's granulomatosis.Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.Tertiary Lymphoid Structures: Autoimmunity Goes Local
P2860
Q26776308-77646291-C9EE-419B-9E51-F7CD1D8032B0Q27025692-F7D801AE-90BC-41C3-9D24-0FF2811FB674Q27490357-19E84346-958A-4DD5-BE15-573832246E8CQ28390438-6680FB2D-4765-48E9-9257-F0254D9A5ADFQ28391531-140A472C-D3BE-4B2A-89BC-C131FB621327Q33372911-5D40E3FF-38E3-40C0-8485-9EA904633847Q34296337-ECE8D1E3-1E6A-4A46-BA84-E02810023AA9Q35098909-5BEFF406-606D-4EDE-8DAF-59C3B088C457Q36504479-E36E9F9A-C489-4156-8BC1-84170C66A361Q36764935-A0A479F7-0B69-4BC4-BB8A-088143FBCE96Q36802625-52167EDF-5E79-4393-A383-E3A396C60D64Q36958331-8BFF3746-75FD-47AE-B761-298E1ACBD63DQ37610414-64920F5C-15E0-4127-8579-ACE31CEF3553Q37710764-24601D42-D58E-42FF-B64D-0ACC2B92E6C3Q37845187-A41316F9-9D6C-4F69-A097-1D1800D47E3EQ38125244-4FA1844D-76E9-4730-9347-948E83F6ADB6Q38146909-DCF0F4B9-C310-46D1-9655-77763DF79C95Q38152651-E1FD4E72-A6B0-40F9-89B2-AB00279457C1Q38341601-AFC964BD-7679-4399-B6E7-CE38738D92CCQ40594099-5A99A791-4C4F-4669-9837-DB3AB45526F7Q41758285-FFC8A17E-6F92-469E-88CF-6E087A40F23BQ42368413-F7B46A37-F86C-4A76-8F57-1773212FA5E5Q42380186-4F36E465-9B9A-4805-BE1D-16D5E7A8432AQ44587629-6D023482-7D95-4E87-BCC6-D787A0AC565BQ45307526-4C999940-1B00-4381-9429-3BA4C410F6DCQ47191744-6EACB654-0FE4-4FD7-AC4C-4E06AAE7F0F1Q50903151-F8DFCA5A-500A-41EA-B53B-1CB6544E0ECBQ51980086-F8295F7F-9653-4551-A1B5-0383AC7A5988Q52311683-8E5AC87D-3807-480F-89A4-35EC9F4B7863Q58746430-69DF2344-BE59-491F-A643-49BBC55D2B8A
P2860
B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
B lymphocyte maturation in Weg ...... genes from endonasal lesions.
@ast
B lymphocyte maturation in Weg ...... genes from endonasal lesions.
@en
type
label
B lymphocyte maturation in Weg ...... genes from endonasal lesions.
@ast
B lymphocyte maturation in Weg ...... genes from endonasal lesions.
@en
prefLabel
B lymphocyte maturation in Weg ...... genes from endonasal lesions.
@ast
B lymphocyte maturation in Weg ...... genes from endonasal lesions.
@en
P2093
P2860
P356
P1476
B lymphocyte maturation in Weg ...... genes from endonasal lesions.
@en
P2093
A C Feller
J A Kraemer
J Voswinkel
K Holl-Ulrich
P Lamprecht
P2860
P304
P356
10.1136/ARD.2005.044909
P407
P577
2005-11-16T00:00:00Z